The Role of Tyro 3 Subfamily Receptors in the Regulation of Hemostasis and Megakaryocytopoiesis
Overview
Authors
Affiliations
Background And Objectives: The molecular mechanisms regulating megakaryocytopoiesis and hemostasis remain largely unknown. The Tyro 3 subfamily of receptor tyrosine kinases (RTK), which is composed of three members (Tyro 3, Axl and Mer), plays important roles in various tissues, such as those in the nervous, immune and reproductive systems. Here, we investigate the roles of the Tyro 3 RTK subfamily in regulating megakaryocytopoiesis and hemostasis.
Design And Methods: Single, double, and triple knock-out mice for the three Tyro 3 RTK were used in the study. Bleeding time, platelet count, megakaryocyte count, megakaryocyte ploidy, rate of proplatelet formation, platelet aggregation and ATP release were used as criteria to evaluate hemostasis, megakaryocytopoiesis and platelet function.
Results: Mice lacking all three receptors had impaired hemostasis and mild thrombocytopenia, which may be due to platelet dysfunction and defective megakaryocytopoiesis. Mice lacking different combinations of two receptors of the Tyro 3 RTK subfamily had normal platelet counts in peripheral blood, but exhibited impaired hemostasis and platelet function. Although knock-out mice for any single receptor had normal hemostasis and megakaryocytopoiesis, they exhibited a mild platelet dysfunction.
Interpretation And Conclusions: The Tyro 3 RTK subfamily plays important roles in regulating hemostasis, megakaryocytopoiesis and platelet function.
MERTK Inhibition as a Targeted Novel Cancer Therapy.
Tanim K, Holtzhausen A, Thapa A, Huelse J, Graham D, Earp H Int J Mol Sci. 2024; 25(14).
PMID: 39062902 PMC: 11277220. DOI: 10.3390/ijms25147660.
From MASH to HCC: the role of Gas6/TAM receptors.
Apostolo D, Ferreira L, Vincenzi F, Vercellino N, Minisini R, Latini F Front Immunol. 2024; 15:1332818.
PMID: 38298195 PMC: 10827955. DOI: 10.3389/fimmu.2024.1332818.
TAM family kinases as therapeutic targets at the interface of cancer and immunity.
DeRyckere D, Huelse J, Earp H, Graham D Nat Rev Clin Oncol. 2023; 20(11):755-779.
PMID: 37667010 DOI: 10.1038/s41571-023-00813-7.
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.
Hedrich V, Breitenecker K, Djerlek L, Ortmayr G, Mikulits W Cancers (Basel). 2021; 13(21).
PMID: 34771611 PMC: 8582520. DOI: 10.3390/cancers13215448.
Suknuntha K, Choi Y, Jung H, Majumder A, Shah S, Slukvin I Front Oncol. 2020; 10:585151.
PMID: 33363015 PMC: 7756118. DOI: 10.3389/fonc.2020.585151.